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Abstract 
With the successful completion of the human genome project and the rapid 
development of sequencing technologies, transcriptome annotation across multiple 
human cell types and tissues is now available. Accurate transcriptome annotation is 
critical for understanding the functional as well as the regulatory roles of genomic regions. 
Current methods for identifying genome-wide active transcription units (TUs) use RNA 
sequencing (RNA-seq). However, this approach requires large quantities of mRNAs 
making the identification of highly unstable regulatory RNAs (like microRNA precursors) 
difficult. As a result of this complexity in identifying inherently unstable TUs, the 
transcriptome landscape across all cells and tissues remains incomplete. This problem can 
be alleviated by chromatin-based approaches due to a well-established correlation 
between transcription and histone modification. 
Here, I present EPIGENE, a novel chromatin segmentation method for 
identifying genome-wide active TUs using transcription-associated histone 
modifications. Unlike existing chromatin segmentation approaches, EPIGENE uses a 
constrained, semi-supervised multivariate Hidden Markov Model (HMM) that models 
the observed combination of histone modifications using a product of independent 
Bernoulli random variables to identify the chromatin state sequence underlying an active 
TU.  
Using EPIGENE, I successfully predicted genome-wide TUs across multiple 
human cell lines. EPIGENE predicted TUs were enriched for RNA Polymerase II (Pol II) 
at the transcription start site (TSS) and in gene body indicating that they are indeed 
transcribed. Comprehensive validation using existing annotations revealed that 93% of 
EPIGENE TUs can be explained by existing gene annotations and 5% of EPIGENE TUs in 
HepG2 can be explained by microRNA annotations. EPIGENE predicted TUs more 
precisely compared to existing chromatin segmentation and RNA-seq based approaches 
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across multiple human cell lines. Using EPIGENE, I also identified 232 novel TUs in K562 
and 43 novel cell-specific TUs in K562, HepG2, and IMR90, all of which were supported 
by Pol II ChIP-seq and nascent RNA-seq evidence. 
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Zusammenfassung 
Mit dem erfolgreichen Abschluss des Humangenomprojekts und der raschen 
Entwicklung von Sequenzierungstechnologien ist nun die Annotation von 
Transkriptomen über mehrere menschliche Zelltypen und Gewebe hinweg verfügbar. 
Eine genaue Annotation des Transkriptoms ist entscheidend für das Verständnis der 
funktionellen und regulatorischen Rolle genomischer Regionen. Aktuelle Methoden zur 
Identifizierung genomweiter aktiver Transkriptionseinheiten (TUs) verwenden die RNA-
Sequenzierung (RNA-seq). Dieser Ansatz erfordert jedoch große Mengen an mRNA, was 
die Identifizierung von hochinstabilen regulatorischen RNAs (wie microRNA-
Vorläufern) schwierig macht. Aufgrund dieser Komplexität bei der Identifizierung von 
inhärent instabilen TUs bleibt die Transkriptomlandschaft über alle Zellen und Gewebe 
hinweg unvollständig. Dieses Problem kann durch Chromatin-basierte Ansätze aufgrund 
einer gut etablierten Korrelation zwischen Transkription und Histonmodifikation 
reduziert werden. 
Hier präsentiere ich EPIGENE, eine neuartige 
Chromatinsegmentierungsmethode zur Identifizierung genomweiter aktiver TUs unter 
Verwendung transkriptionsassoziierter Histonmodifikationen. Im Gegensatz zu 
bestehenden Ansätzen zur Chromatinsegmentierung verwendet EPIGENE ein 
eingeschränktes, halbüberwachtes multivariates Hidden Markov-Modell (HMM), das die 
beobachtete Kombination von Histonmodifikationen unter Verwendung eines Produkts 
unabhängiger Bernoulli-Zufallsvariablen modelliert, um die einer aktiven TU zugrunde 
liegende Chromatin-Zustandssequenz zu identifizieren. 
Mit EPIGENE konnte ich erfolgreich genomweite TUs über mehrere 
menschliche Zelllinien hinweg vorhersagen. Von EPIGENE vorhergesagte TUs wurden 
an der Transkriptionsstartstelle (TSS) und im Genkörper auf RNA-Polymerase II (Pol II) 
angereichert, was darauf hinweist, dass sie tatsächlich transkribiert sind. Eine umfassende 
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Validierung unter Verwendung vorhandener Annotationen ergab, dass 93% der 
EPIGENE-TUs durch vorhandene Genannotationen und 5% der EPIGENE-TUs in HepG2 
durch microRNA-Annotationen erklärt werden können. EPIGENE prognostizierte TUs 
genauer im Vergleich zu bestehenden Ansätzen zur Chromatinsegmentierung und RNA-
Sequenz über mehrere menschliche Zelllinien hinweg. Unter Verwendung von EPIGENE 
identifizierte ich auch 232 neue TUs in K562 und 43 neue zellspezifische TUs in K562, 
HepG2 und IMR90, die alle durch Pol II ChIP-seq- und entstehende RNA-seq-Beweise 
gestützt wurden. 
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Transcription is one of the fundamental processes of life and is necessary for 
the development of living organisms. It involves the formation of single-stranded mRNA 
from a double-helical DNA template. Transcription is carried out by RNA Polymerase II 
(Pol II) in the cell nucleus. The synthesized mRNA is then transported to the cytoplasm, 
where it is translated into proteins by a multi-protein complex called the ribosome. In 
addition to mRNA, Pol II transcribes several other kinds of non-coding RNAs like long 
non-coding RNA (lncRNA), small non-coding RNA (microRNA, snRNA, snoRNA) and 
other stable and unstable RNAs such as stable unannotated transcripts (SUT), cryptic 
unstable transcripts (CUT) and enhancer RNAs (Jacquier, 2009; Xu et al., 2009; Kim et al., 
2010). Besides Pol II, there exist two other kinds of RNA Polymerases, RNA Polymerase I 
(Pol I) and RNA Polymerase III (Pol III). While, Pol I transcribes ribosomal RNAs, which 
are part of the ribosome, Pol III transcribes transferRNAs (tRNA), which are involved in 
the transportation of amino acids to the ribosome, where they are further incorporated to 
proteins.  
1.1 Transcription units and their function 
The transcribed DNA template is called a transcription unit (TU) which can 
either be a protein-coding gene or a precursor for regulatory RNA. A TU has three 
components: promoter, RNA-coding sequence also referred to as the actively transcribed 
region and terminator. The promoter is the region of DNA where RNA Polymerase II 
binds and initiates transcription. The promoter region is followed by the DNA sequence 
that primarily codes for a protein or a regulatory RNA. Transcription ends at the 
terminator region which contains the Poly-A signal that instructs Pol II to terminate 
transcription (Figure 1). 
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Transcription of TUs can produce mRNA as well as other regulatory RNA 
such as lncRNA, microRNA, exogenous small interfering RNA (siRNA), and piwi-
interacting RNA (piRNA). The polyadenylated mRNA is spliced and translated to 
proteins that carry out vital biological processes necessary for the survival of an organism, 
whereas, regulatory RNAs act as sequence-specific transcriptional and post-
transcriptional regulators of gene expression (Bartel, 2004; Meister and Tuschl, 2004; 
Zamore and Haley, 2005; Kim and Nam, 2006).  
 
Transcription is regulated by distal and proximal elements called “enhancers” 
and “promoters” respectively. These regulatory elements contain the binding sites for 
transcription factors (TFs) that decide when a TU is active and how abundantly it is 
transcribed. Therefore, most TUs that are active in certain conditions can be inactive in 
another. Further complicating the picture, is the presence of TUs with a low steady-state 
abundance where the transcribed RNA degradation rate exceeds the TU transcription rate 
(as in the case of microRNA precursors), hence rendering the detection of these TUs 
difficult. Indeed, recent studies have shown the presence of a large number of such TUs 
(Preker et al., 2008), some of which have been associated with diseases like HIV, 
Alzheimer's disease and Cancer (Sethi and Lukiw, 2009; Bail et al., 2010; Shah et al., 2016; 
Wang et al., 2018; Wang, Qin and Tang, 2019; Zhang et al., 2019). For example, the 
microRNA precursor, pri-miRNA-223 is a functional lncRNA in Acute Myeloid Leukemia 
that is rapidly processed out to miR-223 and lncRNA-223. Both these RNAs are expressed 
at different levels and have distinct functions in the myeloid lineage (Mangiavacchi et al., 
2016; Wallace and O’Connell, 2017). This suggests that accurate and efficient identification 
Figure 1: Structure of a transcription unit 
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of TUs would help in improving our understanding of the transcriptomic landscape and 
its regulation across cell types and tissues. 
1.2 Transcription cycle 
Eukaryotic transcription is carried out by Pol II in the cell nucleus. 
Transcription involves a series of stages, often referred to as “the transcription cycle”, in 
which each stage involves specific proteins and protein modifications. The transcription 
cycle can be roughly divided into three stages: initiation, elongation, and termination. 
1.2.1  Initiation 
Transcription begins at the transcription start site (TSS) in which the region 
surrounding the TSS also called the “promoter” directs accurate transcription. According 
to several in vitro transcription studies, six “general transcription factors” (GTFs) (TFIIA, 
TFIIB, TFIID, TFIIE, TFIIF, and TFIIH) assemble at the promoter into the pre-initiation 
complex (PIC) (Nikolov and Burley, 1997) before transcription initiation. It is important 
to note that PIC assembly can be more variable in vivo with the involvement of several 
other TFs, as different promoters suggest different paths to its recognition (Nikolov and 
Burley, 1997; Sikorski and Buratowski, 2009). 
After the formation of the PIC, transcription initiation begins with the 
formation of a jaw-like open complex, where TFIIB aids the insertion of double-stranded 
DNA into the jaw and downstream cleft of Pol II (Sainsbury, Niesser and Cramer, 2013). 
The DNA-helicase TFIIH separates both the strands and inserts the single-stranded DNA 
to the active site of Pol II (Sainsbury, Niesser and Cramer, 2013). With the help of the 
TFIIB-reader domain, Pol II then scans the downstream nucleotides for the TSS and 
initiates the transcription resulting in the formation of the “initial transcribing complex” 
(Kostrewa et al., 2009; Sainsbury, Niesser and Cramer, 2013). 
1.2.2  Elongation 
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Pol II transits from initiation to elongation stage at approximately 150 base-
pairs (bp) downstream of TSS (Mayer et al., 2010). This involves the exchange of initiation 
factors with elongation factors and the phosphorylation of Serine 5 and Serine 7 residues 
in the C-terminal domain (CTD) of Pol II (Mayer et al., 2010; Lidschreiber, Leike and 
Cramer, 2013). After the exchange of initiation factors with elongation factors, Pol II 
undergoes Serine 2 phosphorylation at the CTD (Ahn, Kim and Buratowski, 2004), 
followed by the recruitment of c-Abl (in humans) which triggers binding of the elongation 
factor Spt6 and suppresses transcription termination by blocking the recruitment of 
termination factors (Mayer et al., 2015; Burger, Schlackow and Gullerova, 2019). 
1.2.3  Termination 
Transcription termination occurs at polyadenylation (poly-A) sites, that are 
marked by the presence of a highly conserved consensus sequence motif AATAAA 
located 10-30 bp upstream of the site (McLauchlan et al., 1985; Proudfoot, 2011). The poly-
A site is recognized by cleavage and specificity factors (CPSF), that processes the RNA by 
endonucleolytic cleavage and polyadenylation (Richard and Manley, 2009). Transcription 
continues for several thousand bps after the poly-A site (in humans) and the mechanisms 
that result in the release of Pol II and transcribed RNA from DNA are still unknown. It is, 
however, believed that the speed of transcription elongation and stability of RNA-DNA 
hybrid contributes to the destabilization and release of Pol II from DNA (Skourti-Stathaki, 
Proudfoot and Gromak, 2011; Fong et al., 2015). 
1.3 The histone code of transcription  
Eukaryotic DNA is tightly packed into a macromolecular complex of histone 
proteins and DNA called chromatin. Chromatin can be classified as heterochromatin and 
euchromatin. Heterochromatin is highly compacted and hence genes located in these 
regions are repressed. On the contrary, euchromatin has a low degree of compaction, and 
genes within them can be transcribed. 
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Chromatin comprises of repeating units of 147 DNA base pairs (bp) wrapped 
around an octamer of four histones (2 copies each) H2A, H2B, H3, and H4 called the 
nucleosome. Post-translational chemical modifications to histones in the form of 
acetylation, methylation, phosphorylation, ubiquitination, and sumoylation play a 
significant role in transcription. These modifications are added, removed, and recognized 
by other proteins. Hence, nucleosomes serve as signaling platforms (Turner, 2012) that 
control the regulatory mechanisms in chromatin by enabling the localized activity of 
chromatin signaling networks partaking in transcription and other chromatin-related 
processes (Perner and Chung, 2013). In fact, it has been established that histone 
modifications correlate with transcription (Table 1). For instance, the histone modification 
H3 lysine 4 trimethylation (H3K4me3) and H3 lysine 27 acetylation (H3K27ac) are 
positively correlated to transcription initiation and are enriched at promoters (Bernstein 
et al., 2002; Barski et al., 2007; Creyghton et al., 2010; Karlic et al., 2010) whereas H3 lysine 
9 trimethylation (H3K9me3) is common in heterochromatin. H3K4me3 is involved in the 
recruitment of chromatin remodeling factors like CHD1 and BPTF (Flanagan et al., 2005; 
Li et al., 2006), which result in the opening of chromatin and also prevents the binding of 
repressive NuRD and INHAT complexes (Nishioka et al., 2002; Schneider et al., 2004).  
Table 1: Core histone modifications and their correlation with transcription 
Histone  Correlation to transcription Location 
H3K4me3 positive promoters 
H3K4me1 positive enhancer 
H3K36me3 positive gene bodies 
H3K27ac positive promoters, enhancers 
H3K27me3 negative repressed genes 
H3K9me3 negative heterochromatin 
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This makes the DNA accessible to TFs, hence allowing transcription. Whereas, H3K9me3 
is involved in recruiting heterochromatin protein HP1 to genomic regions, hence 
regulating gene expression and heterochromatin formation. 
1.4 Experimental approaches for studying transcription 
Currently, multiple sequencing techniques exist for studying various aspects 
of transcription. These can be (a) RNA-based, that measure the abundance of processed 
or nascent RNA and characterize the expression levels of TUs in cells, or (b) chromatin-
based, that detect DNA-protein interactions and allow in vivo genome-wide identification 
of binding sites for TFs, histone modifications, and other proteins. 
1.4.1  RNA-seq 
Principle 
RNA sequencing is a widely used technique for measuring the transcriptome 
across cell types and tissues. It identifies the complete set of processed RNAs and their 
isoforms, as well as measures their abundance for a developmental stage or specific 
condition (Mortazavi et al., 2008; Nagalakshmi et al., 2008).  
The protocol starts with isolating the RNA of interest from a given cell type 
(Table 2). The isolated RNA molecules are either first fragmented and then reverse 
transcribed to cDNA or vice versa. The cDNA fragments are amplified and sequenced 
using high-throughput sequencing technology.  
Table 2: RNA-sequencing methods and their benefits 
RNA-seq method Benefits 
mRNA seq polyA selection to sequence mRNA for gene expression analysis 
small RNA seq evaluation of small RNAs (< 200bp) and discovery of novel small RNA 
total RNA seq enables analysis of coding and non-coding RNAs (> 200bp) 
targeted RNA seq sequence and analyze specific TUs of interest  
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RNA-seq approaches require relatively high quantities of target RNAs, hence, 
limiting the accurate identification of highly unstable TUs (like precursors of microRNA, 
enhancer RNA), for which the transcribed RNA concentration is quite less. These can be 
identified by total RNA-seq but this requires an ultra-deep sequencing or a targeted RNA-
seq or small RNA-seq for identifying small RNAs < 200 bp. Additionally, RNA-seq data 
is prone to sequencing errors that negatively impact downstream bioinformatics analysis 
and can lead to incorrect conclusions regarding the set of active TUs (Le et al., 2016; Tong 
et al., 2016). 
1.4.2  Nascent RNA-seq 
Principle 
Recently, nascent RNA-seq approaches have also emerged as a valuable 
method to study Pol II-mediated transcription. These approaches detect nascent RNA or 
primary RNA from the entire pool of cellular RNA, either by chemically inducing point 
mutations or by biochemical enrichment. The isolated RNAs are then reverse transcribed, 
ligated with adapter, amplified, and deep sequenced.  
Most nascent RNA-seq approaches differ considerably in their ability to detect 
or enrich for nascent RNA (Table 3). For instance, chromatin isolation based methods such 
as NET-seq (Mayer et al., 2015), enrich for Pol II-associated RNA and can reliably detect 
transcription termination site (TTS) (Nojima et al., 2015), while run-on techniques like 
GRO-cap (Core et al., 2008) and PRO-cap (Kwak et al., 2013), enrich for capped RNA and 
can reliably detect TSS (Core et al., 2014). Therefore, the choice of the method determines 
the stage of transcription cycle that can be analyzed and additionally influences the 
resolution and stringency of data generated (Wissink et al., 2019).  
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Table 3: Overview of nascent RNA-seq methods 
Method Technique Protocols 
chromatin 
isolation 
Isolation of chromatin-bound RNA by antibodies or high salt 
washes  
Start-seq 
(Williams et al., 
2015), mNET-seq 
(Nojima et al., 
2015) 
run-on Labeling nascent RNAs with 5-bromouridine 5'-triphosphate 
(BrUTP) in presence of anionic detergent sarkosyl, followed 






Labeling the living cells by modified ribonucleotides (such as 
4-thiouridine (4sU)), followed by affinity purification of 
labeled RNA  
TT-seq (Schwalb 
et al., 2016) 
imaging Detection of nascent RNAs by fluorescence in situ 
hybridization of labeled oligos in fixed cells or engineering 
transcripts to encode hairpin-like structure and in vivo 
recognition by tagged cognate binding proteins 
FISH (Bauman et 
al., 1980), 
 MS2-GFP 




Although nascent RNA-seq techniques have proven to be a valuable method 
to study Pol II-mediated transcription, most of these approaches require a high amount of 
input material and are limited to cell cultures and artificial systems (Gardini, 2017). 
Besides, each nascent RNA approach was initially designed to answer very specific 
questions about transcription regulation and hence, identify different stages of 
transcription such as initial transcribing complex (section 1.2.1), CTD modification 
(section 1.2.2), TTS, etc. It is important to note that integration and comparison of results 
from multiple nascent RNA-seq approaches could potentially provide a comprehensive 
overview of transcription and identify genome-wide active TUs. However, methods 
performing such an integrative analysis are yet to be developed. 
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1.4.3  ChIP-seq 
Principle 
ChIP-seq is a technique to analyze DNA-protein interactions. It involves 
chromatin immunoprecipitation followed by massively parallel DNA sequencing (Barski 
et al., 2007; Johnson et al., 2007; Mikkelsen et al., 2007) and is commonly used to detect 
genome-wide binding sites for histone, transcription factors, and other proteins in vivo. 
Currently, with decreasing sequencing costs, ChIP-seq has become an imperative method 
to study transcription regulation and epigenetic mechanisms and can be reliably applied 
for a low number of cells (Gustafsson et al., 2019). 
ChIP-seq protocol starts with crosslinking DNA-bound protein to chromatin 
by exposing the cells to formaldehyde, resulting in covalent bond formation between 
them. The DNA is fragmented using sonication or enzyme digestion and fragments linked 
to the protein of interest are isolated using an antibody that recognizes it. The filtered 
DNA-protein complexes are then reverse cross-linked and the resulting DNA fragments 
are amplified and sequenced. 
Limitation 
One of the major limitations of the ChIP-seq technique is its dependence on 
the quality of the antibody (Park, 2009). Various commercially available antibodies widely 
differ in quality not just across suppliers but also across batches. Antibody quality can be 
evaluated but such methods are time consuming and laborious. Additionally, ChIP-seq 
techniques are comparatively more expensive than RNA-seq and nascent RNA-Seq 
techniques.  
1.5 Computational approaches for identifying transcription units 
Several computational methods have been developed for identifying genome-
wide active TUs. These methods are either (a) RNA-seq based, that assemble the 
transcriptome and identify active TUs using RNA-seq data, or (b) ChIP-seq based, that 
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identify genomic elements by modeling the observed combination of transcription-
associated histone modifications. 
1.5.1  RNA-seq based 
With the decrease in sequencing costs, RNA-seq has emerged as a valuable 
technique for genome-wide TU detection. As a result, most, TU detection approaches like 
idba-Tran, Oases, Cufflinks, Trinity, StringTie, etc (Trapnell et al., 2010; Grabherr et al., 
2011; Schulz et al., 2012; Peng et al., 2013; Pertea et al., 2015) use RNA-seq data. These 
approaches assemble RNA-seq reads either de novo using graph models or use a reference 
genome-guided graph model (Figure 2). 
 
 De-novo assemblers 
De-novo assemblers generate contigs based on the input RNA-seq data. Most 
present-day de novo assemblers like Trinity, Oases, idba-Tran rely on de Bruijn graphs 
generated from the k-mer decomposition of RNA-seq reads. De novo transcriptome 
assembly begins with dividing RNA-seq reads into shorter sequences of length k called k-
Figure 2: Principle of de novo and genome-guided transcriptome assemblers 
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mers and reconstructing the original sequence by overlapping these k-mer sequences. A 
major limitation of de Bruijn graphs is its requirement for a k-mer to start at every position 
along the original sequence so that the graph covers the complete sequence (Chevreux et 
al., 2004). Additionally, this limitation creates a tradeoff regarding the length of the k-
mers. Short k-mers are more likely to fully cover the original sequence but are ambiguous 
with a single k-mer mapping to multiple reads from multiple TUs. Long k-mers avoid 
such ambiguity but may not cover the complete sequence of some TUs. As a result, each 
TU with its unique combination of sequence and abundance levels has a different k-mer 
length for its optimal assembly. Hence, even when using the same de novo assembly 
algorithm, multiple transcriptome assemblies with varying k-mer lengths generate 
different sets of contigs with a different set of correctly assembled contigs. 
Genome-guided assemblers 
The limitations of k-mer decomposition used in de Bruijn graphs are 
alleviated by genome-guided assemblers like Cufflinks and StringTie (Trapnell et al., 2010; 
Pertea et al., 2015) that aligns the RNA-seq reads to the reference genome. These 
assemblers account for introns, by allowing the read mapping for genome-guided 
assembly to split, such that the first half of the read maps to the exon and the second half 
maps to the subsequent downstream exon. This read mapping can be performed by split-
read mappers like STAR, Top-Hat, HPG-Aligner, HISAT, etc. (Trapnell, Pachter and 
Salzberg, 2009; Dobin et al., 2013; Kim, Langmead and Salzberg, 2015; Medina et al., 2016). 
Each of these read mappers uses a different strategy and result in a slightly different read 
mapping which can influence the quality of the subsequent transcriptome assembly.  
Although both de novo and genome-guided assemblers reliably detect TUs 
with high steady-state abundance, detecting unstable TUs such as microRNA precursors 
remains problematic. This is due to the inherent experimental limitation of RNA-seq that 
requires relatively high quantities of target RNA.  
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1.5.2  ChIP-seq based 
Since the successful completion of the human genome project and release of the human 
genome sequence in 2001, several large-scale projects and consortia such as ENCODE, 
NIH Roadmap Epigenomics, DEEP, Blueprint, and IHEC (Feingold et al., 2004; Bernstein 
et al., 2010; Adams et al., 2012; DEEP, 2012; Stunnenberg et al., 2016) have been initiated to 
identify the functional elements of DNA and understand their effects on diseases and 
human development. To accomplish this, large scale genome-wide transcriptome and 
epigenome maps were generated, that allowed the analysis of histone modifications and 
their role in transcription. As a result, in recent years it has been established that essential 
genomic features such as promoter, enhancer, transcribed regions, and heterochromatin 
domain exhibit a characteristic and recurrent histone modification pattern commonly 
referred to as “chromatin state” (Ernst and Kellis, 2012). For example, a combination of 
H3K27ac and H3K4me1 occurs at active enhancers and a combination of H3K27ac and 
H3K4me3 is associated with an active promoter region.  
The deluge of ChIP-seq data for histone modifications (Figure 3) and the 
association of these modifications to transcription allows for an integrative analysis of 
histone modifications also referred to as “chromatin segmentation”. This allows robust 
identification of genomic regions like enhancers, promoters, and insulators as well as 
annotates heterochromatin domain and transcribed regions. Currently, several chromatin 
segmentation approaches such as ChromHMM, EpiCSeg, chroModule, GENOSTAN, etc. 
(Ernst and Kellis, 2012; Won et al., 2013; Mammana and Chung, 2015; Zacher et al., 2017) 
exist that use genome-wide ChIP-seq profiles of histone modifications as input to provide 
genome-wide chromatin state annotation. These approaches use a variety of machine 
learning algorithms with the most prominent one being Hidden Markov Models (HMM). 
HMM is a probabilistic framework used to model a sequence of observations. It assumes 
that the sequence of observations is generated by the underlying hidden states, that emit 
observations according to a particular probability distribution. 
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Hence, it is are ideal for identifying chromatin states based on the observed 
combination of histone modifications. By formal definition, an HMM comprises of: 
𝑄 =  𝑞1, 𝑞2, … 𝑞𝑁 a set of 𝑁 hidden states 
𝑂 =  𝑜1, 𝑜2, … 𝑜𝐾 a sequence of 𝐾 observations 
Figure 3: Distribution of IHEC class 1 histone modifications across multiple consortiums 
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𝑇 =  𝑡11, … 𝑡𝑖𝑗 … 𝑡𝑁𝑁 a transition matrix 𝑇 is a 𝑁 × 𝑁 matrix, where each element 𝑡𝑖𝑗 
represents the probability of moving from hidden state 𝑖 to 
hidden state 𝑗 such that ∑ 𝑡𝑖𝑗
𝑁
𝑗=1 = 1 ∀𝑖 
𝐸 = 𝑒𝑖(𝑜𝑡) an emission matrix, where each element represents the 
probability of an observation 𝑜𝑡 being generated from state 𝑖 
𝜋 =  𝜋1, 𝜋2, … 𝜋𝑁 the initial probability distribution vector, where each element 
𝜋𝑖 is the probability of beginning with state 𝑖 such that 
 0 <  𝜋𝑖 < 1, ∀𝑖 𝜖 𝑁, and ∑ 𝜋𝑖𝑖 ∈𝑁 = 1 
 
In the context of modeling the observed combinations of histone 
modifications,  𝑄 represents the set of hidden chromatin states of an HMM. These hidden 
states are linked by transition probabilities that represent the spatial constraints of how 
the combination of histone modifications occur relative to each other. The emission 
probability vector of each hidden chromatin state represents the probability with which a 
histone modification is observed in that chromatin state. The transition and emission 
probabilities can either be trained using highly confident histone modification data sets 
(supervised) or can be learned de novo from the input chromatin data (unsupervised) 
(Figure 4). The following sections will briefly present the state-of-art approaches used for 
genome-wide chromatin state annotation. 
Unsupervised HMMs 
These HMMs do not rely on prior biological information and therefore require 
the user to interpret and annotate the learned states based on existing knowledge of 
functional genomics. Some of the widely used unsupervised HMMs are ChromHMM, 
EpiCSeg, and GENOSTAN (Mammana and Chung, 2015; Ernst and Kellis, 2017; Zacher et 
al., 2017). All of these approaches use different variants of unsupervised HMM, that 
operates on different kinds of inputs. e.g. ChromHMM models the presence or absence of 
histone modifications in 200 bp bins using a product of independent Bernoulli random 
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variable and hence the input needs to be binarized for this model, whereas, EpiCSeg 
models the raw read counts in 200 bp bins using a negative multinomial distribution and 
hence except for read mapping, it does not rely on preprocessing of data. Both 
ChromHMM and EpiCSeg provide chromatin state annotation without the strand 
information. GENOSTAN addresses this issue by using bidirectional HMMs that 
integrate strand-specific data (e.g. RNA expression) with non-strand specific data (e.g. 
ChIP-seq) to infer directed chromatin states from genomic data de novo. Additionally, all 
of these approaches use the Baum-Welch algorithm (Baum et al., 1970) to fit the model 
parameters and infer the hidden chromatin states using Viterbi or posterior decoding 
(Viterbi, 1967; Fariselli, Martelli and Casadio, 2005). 
 
Figure 4: Core principle underlying existing chromatin segmentation HMMs. 
Chromatin segmentation HMMs model the observed combination of histone 
modifications that are emitted by a sequence of hidden chromatin states. 
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Supervised HMMs 
These HMMs use high confidence labeled data for training the transition and 
emission probabilities and hence do not require the user to explicitly interpret the results. 
An example of a supervised HMM is chroModule (Won et al., 2013) that uses a left-right 
structured HMM to identify genomic modules such as an enhancer, promoter, 
transcribed, repressed and background, and incorporate all these modules into one 
model. It integrates existing biological knowledge into the model by learning the 
transition and emission probabilities on preselected training sets. The individual models 
are trained separately using the Baum-Welch algorithm (Baum et al., 1970) and all the 
modules are then linked to construct the final model. Chromodule operates at 100 bp 
resolution and each 100 bp bin is assigned to the hidden chromatin state using the Viterbi 
algorithm (Viterbi, 1967). 
Dynamic Bayesian Networks 
In addition to HMMs, dynamic bayesian networks (DBN) has also been used 
to provide genome-wide chromatin state annotations. DBNs are similar to HMM with 
several hidden chromatin states and multiple observation tracks. A well-known 
application of DBN for genome-wide chromatin state annotation is Segway (Hoffman et 
al., 2012). Unlike other approaches, Segway operates at a 1-bp resolution and is 
comparatively slower than HMM-based approaches (Mammana and Chung, 2015). 
Although the above-mentioned chromatin segmentation approaches identify 
important genome regions such as enhancers, promoters, transcribed regions, etc., they 
fail to identify genome-wide active TUs as the underlying model does not constrain the 
chromatin state sequence to begin with a TSS and end with a TTS. 
1.6 Aim of the thesis 
As described earlier, accurate identification of TUs is essential to better 
understand the transcriptomic landscape of a cell. Most of the existing approaches either 
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fail to identify short-lived TUs or are unable to identify TUs due to the usage of a flexible 
model. 
In this thesis, I address these shortcomings by developing a semi-supervised 
HMM referred to as EPIGENE. EPIGENE models the observed combination of histone 
modifications to predict genome-wide active TUs. In contrast to existing chromatin 
segmentation approaches, EPIGENE assigns a direction (forward or reverse) to the TUs 
which is essential to characterize transcription.  
This thesis is divided into three parts. Chapter 2 introduces, validates, and 
compares EPIGENE predictions using existing gene annotations, Pol II ChIP-seq, nascent-
RNA, RNA-seq data, and chromatin segmentation approaches. I compare EPIGENE with 
existing RNA-seq based and chromatin segmentation approaches and also demonstrate 
its applicability across cell lines and tissues. Chapter 3 presents the methods and analysis 
strategies that have been used in this thesis. Finally, I critically discuss EPIGENE and also 
suggest future improvements in Chapter 4. 
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2 Results 
The results presented in this chapter were published as a peer-reviewed research article in 
Epigenetics and Chromatin (Sahu et al. 2020). Please refer to Page xi for author contributions. 
 
A longstanding challenge in molecular biology is to elucidate the 
transcriptomic landscape across cells and tissues. This task becomes even more 
challenging due to the presence of TUs that gives rise to unstable RNAs like microRNA 
precursors. Analysis of genome-wide ChIP-seq profiles of histone modifications in 
humans has established the presence of characteristic histone modification patterns in 
different parts of a TU. Thus, an integrative analysis of transcription-associated histone 
modifications can be used to identify genome-wide active TUs.    
In this thesis, I validate this hypothesis across multiple cell lines by developing 
a novel computational method “EPIGENE” that models the observed combination of 
transcription-associated histone modifications to predict genome-wide active TUs. 
EPIGENE is the first method that uses histone modifications for identifying genome-wide 
TUs. 
In this chapter, I present the EPIGENE approach and validate EPIGENE 
predictions with existing gene annotations, RNA-seq, and ChIP-seq datasets. I also 
discuss the performance of EPIGENE in gold standard datasets and its comparison with 
existing RNA-seq and chromatin segmentation approaches. Additionally, I demonstrate 
the applicability of EPIGENE across multiple cell lines and present multiple examples of 
cell-type specific unannotated TUs and cell-type specific microRNA precursors that could 
not be identified by existing approaches due to the absence of RNA-seq evidence.  
2.1 Schematic overview of EPIGENE 
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EPIGENE learns the TU state signatures using a multivariate HMM, which 
probabilistically models the combinatorial presence and absence of IHEC class 1 histone 
modifications.  
2.1.1  EPIGENE input 
EPIGENE requires a class matrix as input where each row corresponds to a 
200 bp non-overlapping genomic interval called bin and each column corresponds to a 
histone modification. The values in the matrix represent the presence or absence of the 
histone modification in the 200 bp bin. The class matrix was computed by dividing the 
mappable regions of the genome into non-overlapping 200 bp bins and computing the 
ChIP and control read counts in each bin for each histone modification. The ChIP and 
control read counts were subsequently converted to the presence and absence calls using 
normR (Kinkley et al., 2016) (Figure 5; see section 3.2).  
2.1.2  The EPIGENE model 
EPIGENE models the class matrix using a multivariate HMM. The 
multivariate HMM has 14 TU states and 3 background states (Figure 6A), where each TU 
state represents individual components of a gene such as TSS, exon, intron, etc., and each 
background state represents genomic regions other than TU such as an enhancer, 
heterochromatin, etc. The TU states were duplicated, running from TSS to TTS and from 
TTS to TSS, hence allowing the identification of TUs on both forward and reverse strands. 
In contrast to existing chromatin segmentation approaches, the transition and 
emission probabilities of EPIGENE were trained in a semi-supervised manner, to obtain 
a probabilistic model for the chromatin state sequence underlying active TUs. The model 
constrains this chromatin state sequence to always begin with a TSS state, proceed 
through exon and intron states, and end with a TTS state. Hence, naturally recovering the 
genomic region that is spanned by a putative TU - a task that is much harder using 
unconstrained chromatin state models, such as ChromHMM or EpiCSeg.  
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Given the class matrix and the transition and emission probabilities, EPIGENE 
outputs a bin-state vector where each bin is assigned to TU or background state. The 
vector is further filtered to obtain active TUs that begin with a TSS state and end with a 
TTS state (Figure 6B) (method details in section 3.3). 
2.1.3  EPIGENE model parameters 
The transition probabilities of the HMM represents the spatial constraints of 
how the combination of histone modifications occur relative to each other, and, the 
emission probabilities represent the probability with which a histone modification occurs 
in a TU state. 
Figure 5: Preparing input data for EPIGENE model 
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Figure 6: EPIGENE workflow and example of EPIGENE TU (a) Schematic overview 
of EPIGENE framework. (b) An example of EPIGENE prediction. EPIGENE 
predictions of METTL4 and NC80 gene show an enrichment of H3K27ac and 
H3K4me3 at TSS (tracks shown in light violet), H3K36me3 in gene body (tracks shown 
in green), enhancer mark H3K4me1 few bps upstream or downstream of TSS (tracks 
shown in pink), RNA Polymerase II in TSS and gene body (tracks shown in blue). The 
predictions also show an absence of repression marks H3K27me3 and H3K9me3 
(tracks shown in black). The corresponding RNA-seq evidence in this genomic region 
can be seen in the lower-most track (track shown in dark pink) 
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To probabilistically model the combinatorial absence/presence of different 
histone modifications and the topology of TU and background states, the transition and 
emission probabilities were trained in a semi-supervised manner (refer section 3.4). Except 
for the transition between TSS to TTS and vice versa, the transition probabilities between 
the TU states were trained using GENCODE  (Frankish et al., 2019) annotations. The 
emission probabilities of the TU states were trained on the GENCODE TUs that show 
enrichment of Pol II in the reference epigenome, which was generated as per IHEC 
guidelines (IHEC, 2012) (see section 3.1 and  Table S1). The emission and transition 
probabilities between the background states were trained in an unsupervised manner. 
Additionally, the transition probabilities from or to either the TSS and TTS states and the 
transition probabilities between TSS and TTS states were trained in an unsupervised 
manner. This semi-supervised training of model parameters ensures the applicability of 
the model across multiple cell-types and tissues without the need for additional training 
or tuning of parameters. 
2.2 Validation of EPIGENE predicted TUs 
To access the quality of EPIGENE predicted TUs, I validated the predicted 
TUs with existing gene annotations, RNA-seq, and ChIP-seq evidence in the K562 cell line.  
The validation with RNA-seq evidence was performed using existing RNA-seq based TU 
identification approaches, while the validation with ChIP-seq evidence was performed 
using ChIP-seq profiles of Pol II and histone modifications. 
2.2.1  Validation with existing gene annotations and RNA-seq  
I created a consensus TU set to investigate the presence of unannotated 
EPIGENE TUs (24,571 TUs; Table S2) and also to estimate the proportion of EPIGENE 
TUs that are also supported by RNA-seq and existing gene annotations. The RNA-seq TUs 
were obtained from StringTie (101,656 TUs; Table S3) and Cufflinks (32,079 TUs; Table 
S4). A union operation between EPIGENE, StringTie, and Cufflinks predictions was 
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performed to obtain the consensus TU set (refer section 3.7). The consensus TU set 
containing 24,874 TUs was overlapped with GENCODE and CHESS annotations (Pertea 
et al., 2018; Frankish et al., 2019) to compute the fraction of annotated and unannotated 
EPIGENE TUs that are: (a) supported RNA-seq evidence, and (b) exclusive to EPIGENE 
(Figure 7).  
 
Figure 7: EPIGENE TUs overlapping gene annotations and RNA-seq TUs 
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I found that 10,077 (8605 + 718 + 586) out of 24,874 TUs in the consensus TU 
set were predicted by EPIGENE. 92.5% (9,323 out of 10,077) of these EPIGENE TUs 
overlapped with existing gene annotations irrespective of the TU strand. I identified 1304 
(718: annotated, 586: unannotated) EPIGENE-exclusive and 14,797 (11,584: annotated, 
3213: unannotated) RNA-seq exclusive TUs.  
Further integration of Pol II and nascent RNA-seq (TT-seq and GRO-seq) data 
revealed that 88.4% (518 out of 586) of EPIGENE unannotated TUs were supported by 
either nascent RNA-seq or Pol II ChIP-seq evidence and 40% (232 out of 586) of EPIGENE 
unannotated TUs were supported by both nascent RNA-seq and Pol II ChIP-seq data 
(please refer Sahu et al., 2020, Supplementary file S2). 
2.2.2  Validation with Pol II and histone modifications 
As mentioned in section 1.2, transcription in eukaryotes is regulated by Pol II 
phosphorylation in CTD at serine 2,5 and 7.  The promoter regions are characterized by a 
strong phosphorylation signal for serine 5 and 7, whereas the transcription elongation 
regions show a strong phosphorylation signal for serine 2 and 5. Here, I used genome-
wide ChIP-seq profiles of Pol II, that were generated using four antibodies (PolII8WG16, 
PolIIS2PH5, PolIIS5P4H8, and PolIIS7P4E12), to compute Pol II occupancy at TSS and 
gene body respectively. 
To estimate the correctness of EPIGENE predictions, I computed the 
enrichment of histone modifications and Pol II in predicted TUs using normR. I found that 
majority of EPIGENE TUs showed typical TU characteristics with high enrichment of 
H3K4me3 and H3K27ac in TSS and H3K36me3 in the gene body (Figure 8A; Figure S1). 
A significant proportion of EPIGENE TUs (78%) showed enrichment of Pol II in TSS and 
gene body (Figure S1).  
I further integrated RNA-seq data in this analysis. The RNA-seq RPKM values 
were computed for EPIGENE TUs and the TUs were classified as high RPKM TUs and 
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low RPKM TUs based on RNA-seq evidence (threshold = upper quartile of RPKM 
distribution). I visualized the distribution of Pol II enrichment score for both these TU 
classes (Figure 8B) and found the presence of 622 EPIGENE TUs that are enriched for Pol 
II but had very low or no RNA-seq evidence. Additional overlap with GENCODE and 
CHESS gene annotations revealed that 3.8% (24 of 622) of these TUs are unannotated and 
96% (598 of 622) of these TUs are annotated. 
 
2.3 Method comparison 
Figure 8: Correctness of EPIGENE TUs (a) EPIGENE-estimated parameters for K562 
using 17 chromatin states, ranging from 0 (white) to 1 (dark green). (b) Distribution of 
Pol II enrichment score in EPIGENE predictions. The EPIGENE predictions are 
classified as: high RPKM (RPKM ≥ upper quartile) and low RPKM (RPKM < upper 
quartile) based on RNA-seq evidence in predicted transcripts 
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Currently, there is no gold standard set for TUs across cell types and tissues. 
However, as mentioned in section 1.4, several experimental approaches exist to study Pol 
II-mediated transcription. Hence, to perform a comprehensive and fair comparison, for 
each cell line, a cell-specific gold standard TU set was defined based on the enrichment 
profiles of Pol II ChIP-seq and nascent RNA-seq (Figure 9A). These gold standard cell-
specific TU sets were then used to quantitatively compare EPIGENE with existing 
chromatin segmentation and RNA-seq based TU prediction methods (analysis details in 
section 3.8). The method comparison was performed in two stages: within cell line and 
cross cell line comparison using cell-specific gold standard TU set as a performance 
indicator (Figure 9B). 
2.3.1  Comparison with RNA-seq based approaches 
EPIGENE was compared with two widely used RNA-seq based methods 
StringTie and Cufflinks, across multiple human cell lines. The choice of RNA-seq based 
methods was due to the superior performance of genome-guided assemblers and also due 
to the availability of high-quality reference genome in humans (Liu et al., 2016; Venturini 
et al., 2018).  
 
Figure 9: Defining the gold standard for method comparison (a) Set of 
gold standard regions obtained by combining Pol II ChIP-seq and nascent 
RNA-seq. (b) Contingency matrix used for method comparison. 
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Within cell line comparison 
This comparison was done on the K562 cell line,  the ChIP-seq profile of Pol II 
in the K562, and the nascent RNA TUs supported by TT-seq and GRO-seq evidence in 
Schwalb et al (Schwalb et al., 2016) were used as a performance indicator. For this 
comparison, I used the ChIP-seq profiles of Pol II obtained using the PolIIS5P4H8 
antibody because it identifies Pol II occupancy both at TSS and gene body. 
I performed the method comparison at 200 bp resolution and found that 
EPIGENE reports higher AUC (PRC: 0.83, ROC: 0.85; Figure 10A, 10B) than StringTie 
(PRC: 0.77, ROC: 0.82) and Cufflinks (PRC: 0.60, ROC: 0.63) in both Precision-Recall (PRC) 
and Receiver-Operating Characteristic (ROC) curve.  
This analysis was repeated for 3 different resolutions (50 bp, 100 bp, and 500 
bp) and EPIGENE consistently reported a superior performance than StringTie and 
Cufflinks for varying resolutions (Figure 10C). Overall, Cufflinks reported a lower AUC 
than EPIGENE and StringTie, which is likely due to the usage of RABT assembler 
resulting in a large number of false positives (Janes et al., 2015).  
StringTie also reported a lower AUC than EPIGENE for varying resolutions. 
Further examining the sensitivity, precision, and specificity values for EPIGENE, 
StringTie and Cufflinks revealed that lower AUC for RNA-seq based methods was due to 
spurious read mappings of RNA-seq that results in higher false positives in StringTie and 
Cufflinks. Figure S2 shows an example of StringTie and Cufflinks TU that was identified 
due to read mapping. The TU exactly overlaps with a repetitive sequence occurring in 
chromosomes 1, 5, 6, X. 
Cross cell line comparison 
In this comparison, I used datasets from 2 cell lines provided by ENCODE 
(Feingold et al., 2004) and DEEP (DEEP, 2012) consortium: 
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Figure 10: Comparing EPIGENE, STRINGTIE, and CUFFLINKS in K562 (A) 
Receiver-operating characteristic curve. (B) Precision–recall curve. (C) Area under 
ROC and PRC curve for varying Pol II resolution for EPIGENE, Cufflinks and 
StringTie 
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 IMR90: ChIP-seq profiles of core histone modifications in lung fibroblast cells 
obtained from Lister et al (Lister et al., 2009), ChIP-seq profile of Pol II obtained 
from Dunham et al (Dunham et al., 2012), two control experiments (one each for 
Pol II (Dunham et al., 2012) and histone modifications (Lister et al., 2009)), RNA-
seq profile obtained from Dunham et al (Dunham et al., 2012) and GRO-seq profile 
obtained from Jin et al (Jin et al., 2013). 
 HepG2, 2 replicates: ChIP-seq profiles of core histone modifications and control in 
hepatocellular carcinoma and matched RNA-seq profiles obtained from Salhab et 
al (Salhab et al., 2018), where two replicates were available for each histone 
modification and RNA-seq. ChIP-seq profiles of Pol II and control were obtained 
from Dunham et al (Dunham et al., 2012) and the GRO-seq profile was obtained 
from Bouvy-Liivrard et al (Bouvy-Liivrand et al., 2017). 
I applied the K562-trained EPIGENE model to predict active TUs in HepG2 
and IMR90 and compared its predictions with that of StringTie and Cufflinks. The GRO-
seq profiles and ChIP-seq profiles of Pol II were used to define the cell-specific gold 
standard TU set in HepG2 and IMR90.  The method comparison was performed with a 
similar strategy used in the previous section.  
I found that the K562-trained EPIGENE model consistently reported higher 
AUC than StringTie and Cufflinks in both PRC and ROC curves (Figure 11, Figure S3, 
and Table 4-6), hence suggesting that EPIGENE predicts TUs with superior precision than 
RNA-seq based methods across multiple cell lines. 
Table 4: AUC-ROC and AUC-PRC values for EPIGENE, CUFFLINKS, and 
STRINGTIE in IMR90 
Method AUC-ROC AUC-PRC 
EPIGENE 0.77 0.78 
STRINGTIE 0.72 0.68 
CUFFLINKS 0.54 0.54 
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Table 5: AUC-ROC and AUC-PRC values for EPIGENE, CUFFLINKS, and 
STRINGTIE in HepG2 replicate 1 
Method AUC-ROC AUC-PRC 
EPIGENE 0.77 0.75 
STRINGTIE 0.77 0.73 
CUFFLINKS 0.64 0.61 
 
 
Figure 11: Comparing K562-trained EPIGENE models, STRNGTIE and 
CUFFLINKS across cell lines EPIGENE reports a superior AUC compared to 
STRINGTIE and CUFFLINKS. 
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Table 6: AUC-ROC and AUC-PRC values for EPIGENE, CUFFLINKS, and 
STRINGTIE in HepG2 replicate 2 
Method AUC-ROC AUC-PRC 
EPIGENE 0.80 0.80 
STRINGTIE 0.78 0.73 
CUFFLINKS 0.64 0.61 
 
2.3.2  Comparison with chromatin segmentation methods 
As mentioned in section 1.5.2, currently several chromatin segmentation 
approaches exist that provide genome-wide chromatin state annotation using histone 
modifications. It is important to note that these approaches were initially developed for 
chromatin state annotation and therefore, the model parameters do not represent the 
topology of a TU. Here, I evaluate the performance of these approaches in identifying 
genome-wide active TUs. I compared EPIGENE predictions with the predictions of a 
widely used chromatin segmentation approach, ChromHMM which also uses a binning 
strategy.  Segway was not included in this comparison because it is comparatively slower. 
Additionally, it operates at a 1-bp resolution and, hence, restricts a fair comparison across 
multiple cell types and tissues.  
It is important to note that chromatin annotations obtained from ChromHMM 
do not contain the strand information, hence, to perform a fair comparison, ChromHMM 
was evaluated for TU prediction in a strand-specific and unstranded manner. Chromatin 
state annotations across multiple cell lines were obtained with ChromHMM using the 
same set of histone modifications that were used as features in the EPIGENE model. These 
chromatin state annotations were then filtered to obtain strand-specific and unstranded 
TUs. Strand-specific TUs were obtained by linking active TSS (state 9 in Figure 6B) and 
transcription elongation states (states 4, 5, and 8 in Figure 12A). In this case, an active TU  
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Figure 12: Comparing K562-trained EPIGENE with ChromHMM across cell lines  
(A) Emission probabilities of ChromHMM model trained in K562 cell line. (B-E)  
Performance of K562-trained EPIGENE model and K562-trained ChromHMM model 
in K562, IMR90 and HepG2 
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is defined as a genomic region that begins with an active TSS state and proceeds through 
transcription elongation states in forward or reverse direction. An active TSS state was 
defined by an enrichment of H3K27ac and H3K4me3 and a transcription elongation state 
is defined by an enrichment of H3K36me3. For unstranded TUs, it was assumed that a TU 
is a genomic region that is enriched for H3K36me3, hence, unstranded TUs were obtained 
by filtering the ChromHMM chromatin state annotations for transcription elongation 
states (states 4, 5 and 8 in Figure 12A). The performance of EPIGENE was compared with 
ChromHMM using the cell-specific gold standard regions defined in section 2.3.1. As 
evident from Figure 12B-E, Figure S4 and Table 7-10 EPIGENE consistently report a 
superior performance than ChromHMM strand-specific and ChromHMM unstranded 
TUs.  
 
Table 7: AUC-ROC and AUC-PRC values for EPIGENE, chromHMM strand-
specific, and chromHMM unstranded in K562 
Method AUC-ROC AUC-PRC 
EPIGENE 0.85 0.83 
ChromHMM stranded 0.73 0.77 
ChromHMM unstranded 0.79 0.80 
 
Table 8: AUC-ROC and AUC-PRC values for EPIGENE, chromHMM strand-
specific, and chromHMM unstranded in IMR90 
Method AUC-ROC AUC-PRC 
EPIGENE 0.77 0.78 
ChromHMM stranded 0.69 0.75 
ChromHMM unstranded 0.60 0.63 
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Table 9: AUC-ROC and AUC-PRC values for EPIGENE, chromHMM strand-
specific, and chromHMM unstranded in HepG2 replicate 1 
Method AUC-ROC AUC-PRC 
EPIGENE 0.75 0.77 
ChromHMM stranded 0.63 0.69 
ChromHMM unstranded 0.67 0.67 
 
Table 10: AUC-ROC and AUC-PRC values for EPIGENE, chromHMM strand-
specific, and chromHMM unstranded in Hepg2 replicate 2 
Method AUC-ROC AUC-PRC 
EPIGENE 0.80 0.80 
ChromHMM stranded 0.71 0.77 
ChromHMM unstranded 0.66 0.69 
 
The lower AUC of unstranded and strand-specific ChromHMM TUs was due 
to the presence of intermediate low coverage states (state 2 in Figure 12A) and intronic 
enhancers that resulted in shorter strand-specific and unstranded ChromHMM TUs 
(Figure 13) and fewer strand-specific ChromHMM TUs. 
2.4 EPIGENE TUs with negligible RNA-seq evidence 
Previous validations and comparisons of EPIGENE with existing gene 
annotations, Pol II ChIP-seq profiles, and existing RNA-seq approaches (section 2.2 and 
2.3) revealed the presence of EPIGENE TUs that were supported by nascent RNA and Pol 
II evidence but with negligible RNA-seq evidence. In this section, I analyze these TUs 
across multiple cell lines by: (a) identifying cell-specific TUs that showed TU 
characteristics but lacked RNA-seq evidence, and (b) investigating the presence of 
microRNA precursors that were not identified by RNA-seq. 
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2.4.1  EPIGENE predicts cell-specific TUs 
EPIGENE predicted TUs in K562, IMR90, and HepG2 cell lines were combined 
using union operation to create a consensus EPIGENE TU set (refer section 3.9 for analysis 
details). This consensus TU set constituted 18,248 TUs, of which ~78% TUs were enriched 
for Pol II. I identified 10,233 differentially enriched TUs, of which 8047 TUs were exclusive 
to cell lines (HepG2: 1255; IMR90: 2545; K562: 4247; Figure S5). Additional integration of 
RNA-seq evidence revealed the presence of 43 highly confident cell-specific TUs that 
lacked RNA-seq evidence but showed typical TU characteristics, with enrichment of Pol 
II, GRO-seq, H3K27ac and H3K4me3 at TSS and H3K36me3 and Pol II in the gene body. 
Figure 14 shows one such K562 exclusive EPIGENE TU located between lncRNA RP5-
Figure 13: Length distribution of EPIGENE and ChromHMM TUs across cell lines 
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952N6.1 and CASP3P1. This TU was additionally supported by Pol II and nascent RNA 
evidence but lacks RNA-seq evidence. 
 
2.4.2  EPIGENE predicts microRNAs precursors  
MicroRNA precursors are a class of TUs that gives rise to  ~70 bp pre miRNA which is 
further processed by endonucleases (Bartel, 2004; He and Hannon, 2004) to small, 
evolutionally conserved, non-coding and mature microRNAs (Lagos-Quintana et al., 2001; 
Lee and Ambros, 2001). 
Figure 14: Example of EPIGENE-predicted TU that lacks RNA-seq evidence. The TU 
was predicted to be active in K562 but not in HepG2 and IMR90, and is located 
between pseudogene CASP3P1 and lncRNA RP5-952N6.1. The TU (shown in dark 
blue in EPIGENE-K562 track) shows an enrichment of H3K27ac and H3K4me3 at TSS 
(tracks shown in light violet), H3K36me3 in gene body (tracks shown in green), 
enhancer mark H3K4me1 few bps upstream of TSS (tracks shown in pink), GRO-seq 
in TSS (tracks shown in brown), K562 Pol II in TSS and gene body (tracks shown in 
blue). The TU also shows an absence of repression marks H3K27me3 and H3K9me3 
in K562 (tracks shown in black). We additionally observe the enrichment of repression 
mark in H3K27me3 in HepG2 and IMR90 indicating that the region is repressed in 
both these cell lines. There is a negligible RNA-seq evidence (shown in dark pink in 
K562-RNA-seq track) for this predicted TU. 
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These RNAs have been shown to regulate several fundamental biological processes such 
as differentiation, development, and apoptosis by post-translational regulation of target 
genes via gene silencing (Plasterk, 2006; Carleton, Cleary and Linsley, 2007) and are 
involved in disease pathogenesis (Calin and Croce, 2006). Due to the short lifetime of 
microRNA precursors, identifying them with existing RNA-seq based TU detection 
approaches becomes challenging. 
I created a consensus TU set for individual cell lines (K562, IMR90, and 
HepG2) by combining the predictions of EPIGENE, StringTie, and Cufflinks. I integrated 
miRbase annotation (Griffiths-Jones et al., 2006) to the consensus TU set and found that 
655 EPIGENE TUs in the HepG2 cell line is supported by microRNA annotations. 
 
These potential microRNA TUs constitutes 5% of total EPIGENE TUs that are 
common in both HepG2 replicates. Further integration of Pol II and RNA-seq data, 
revealed that majority of these TUs were supported by Pol II and RNA-seq evidence 
(Figure 15 and S6). Additionally, I found 2 microRNA TUs in HepG2, that were enriched 
Figure 15: EPIGENE TUs overlapping miRbase annotations. Overview of 
potential primary miRNAs predicted by EPIGENE in HepG2 
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for H3K4me3, H3K27ac, GRO-seq and Pol II at TSS, and H3K36me3 in their gene body 
but lacked RNA-seq evidence. Figure 16 shows an example of a potential microRNA TU 
in HepG2, which overlaps with a microRNA cluster, located between lncRNA RP11-
738B7.1 and NRF1 gene. This microRNA cluster has been shown to arise from the same 





Figure 16: EPIGENE-predicted TU overlapping a microRNA cluster in HepG2 cell 
line. This region is located between lincRNA RP11-738B7.1 and gene NRF1. The TU 
shows an enrichment of H3K27ac and H3K4me3 at TSS (tracks shown in light violet), 
H3K36me3 in gene body (tracks shown in green), enhancer mark H3K4me1 few bps 
upstream and downstream of TSS (tracks shown in pink), GRO-seq in TSS (tracks 
shown in brown) and RNA Polymerase II ChIP-seq in TSS (tracks shown in blue). The 
predictions also show an absence of repression marks H3K27me3 and H3K9me3 
(tracks shown in black) and RNA-seq evidence (tracks shown in dark pink) 
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3 Methods 
Parts of this chapter were published as a peer-reviewed research article in Epigenetics and 
Chromatin (Sahu et al. 2020). For detailed author contributions, please refer to Page xi. 
 
In this chapter, I provide additional details about the steps and methods used 
in data pre-processing and analyzing EPIGENE predictions. Additionally, I also describe 
the strategies used for training and evaluating EPIGENE. 
3.1 Data pre-processing 
As mentioned in section 2.1, EPIGENE was trained on the reference 
epigenome. The reference epigenome of K562 cell line was generated as per IHEC 
standards. The ChIP-seq libraries for IHEC class 1 histone modifications and Pol II were 
prepared by my colleagues (mentioned in Author Contributions in Page xi) as per the 
instructions mentioned in my publication (Sahu et al., 2020). Other datasets used in 
performance evaluation of EPIGENE  were download from GEO (Clough and Barrett, 
2016), ENCODE, European Genome-phenome Archive (EGA), and European Nucleotide 
Archive (ENA) (Feingold et al., 2004; Leinonen et al., 2011; Lappalainen et al., 2015; Clough 
and Barrett, 2016) (refer Table S1). 
3.1.1  Sequencing and processing ChIP-seq data  
The ChIP-seq libraries for histone modifications and Pol II were sequenced on 
Illumina Highseq 2500 resulting in 50 bp reads. The reads were aligned to genome 
assembly “hs37d5” using STAR aligner (Dobin et al., 2013) with the parameter setting: 
intronMax = 1 and the duplicate reads were located and marked using Picard tools 
(Wysoker, A., Tibbetts, K., and Fennell, 2013). The quality of ChIP-seq data was then 
evaluated using the plotFingerprint method of deepTools (Ramírez et al., 2014). 
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3.1.2  Processing of RNA-seq data 
The reads from RNA-seq experiments were download from ENA (SRR 
315336, 315337 for K562), EGA (EGAD00001002527 for HepG2), and ENCODE 
(ENCSR00CTQ for IMR90). The quality of reads was first evaluated with FastQC 
(Andrews, 2010) and the reads were then aligned to genome assembly ”hs37d5” with 
STAR aligner.  
3.1.3  Processing of Nascent RNA-seq data 
The genome-wide TU set for K562 that was identified based on TT-seq was 
downloaded from GEO (GSE 75792). As these TUs were identified using hg38, the 
genome-coordinates of TUs were lifted over to hg19 for valid and efficient comparison. 
The raw reads from the GRO-seq experiment for HepG2 were downloaded from GEO 
(GSM2428726).  These raw reads were aligned to hg19 and the processing was done based 
on the steps described in Bouvy-Liivrard et al. For IMR90, I used the TU annotation 
described in Jin et al which was generated using GRO-seq. This annotation was obtained 
using hg18 genome build, hence, to perform a fair and valid comparison, the TUs were 
lifted over to hg19. 
3.2 Binarization of ChIP-seq profiles 
As mentioned in section 2.1.1, EPIGENE requires the enrichment scores of 
IHEC class 1 histone modifications in binarized form i.e as presence or absence calls 
referred to as “class matrix”.  This was done by partitioning the mappable regions of the 
genome to contiguous non-overlapping genomic intervals of the same size called bins. 
Currently, EPIGENE performs the binarized (presence or absence call) enrichment calling 
at 200 bp resolution as this roughly corresponds to the size of a nucleosome and spacer 
regions. 
3.2.1  Obtaining read counts 
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The read counts for all genomic bins were computed from ChIP and input 
alignment files using the bamCount function of the bamsignals R package (Mammana and 
Helmuth, 2015), with the following parameter settings: paired.end = “midpoint”, mapqual 
= 255, and filteredFlag = 1024. mapqual was set to 30, for publicly available datasets that 
were aligned using bwa or bowtie (Langmead et al., 2009; Li and Durbin, 2009). 
3.2.2  Binarized enrichment calling 
After obtaining the ChIP and input read counts for individual histone 
modifications, in each 200 bp bin, the binarized enrichment score (1: present or 0: absent) 
of histone modifications 𝐸(𝑏𝑖𝑛, 𝐻𝑀𝑖)  (where i ∈ IHEC class I histone modifications) and 
Pol II 𝐸(𝑏𝑖𝑛, 𝑃𝑜𝑙 𝐼𝐼𝑗) (where j ∈ (Pol II.8WG16, Pol IIS2P.H5, Pol IIS5.4H8, Pol IIS7P.4E12)) 
across all bins, were computed using enrichR and getClasses functions from normR 
package. For accurate binarized enrichment calling, I prefilter the genomic bins such that 
bins with input and ChIP read counts > 0 should be considered for background estimation. 
This was done by setting, binFilter = “zero” in enrichR. The binary enrichment scores for 
individual bins were computed using getClasses. This step results in the “class matrix” 
which was used as an input to the multivariate HMM. 
3.3 The EPIGENE model 
EPIGENE models the class matrix of histone modifications using a semi-
supervised multivariate HMM to predict genome-wide active TUs. The class matrix 𝐶 is a 
𝐴 × 𝐵 matrix, where 𝐴 = number of 200 bp bins, and 𝐵 = number of histone modifications 
(in this case, 𝐵 = 6) and each matrix entry 𝐶𝑖𝑗 represent the presence or absence of the 𝑗th 
histone modification in the 𝑖th bin. As mentioned earlier in section 2.1.2, the model 
consists of 17 hidden states (14 TU states and 3 background states) and each row of the 
class matrix corresponds to one of these hidden states. The transition probabilities 
between the hidden states capture the position biases of TU states relative to each other. 
The emission probabilities of each hidden state represent the probability with which each 
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histone modification occurs in the hidden state. The transition and emission probabilities 
were trained in a semi-supervised manner which is discussed in the forthcoming section. 
Given this multivariate HMM and the model parameters, the algorithm: 
1. assigns the initial probabilities 
2. fits the transition and emission probabilities using the Baum-Welch 
algorithm (Baum et al., 1970). 
3. infers the final segmentation. The final segmentation i.e. the sequence 
of hidden states can be inferred using posterior decoding or Viterbi 
algorithm. As I was concerned about the most probable sequence of 
active TUs rather than the most probable hidden state for each bin, the 
final segmentation was obtained using the Viterbi algorithm. 
4. filters the output vector i.e. the sequence of hidden states. The vector 
of hidden states was filtered to obtain genomic regions beginning with 
a TSS state and terminating with a TTS state.   
3.4 Training the transition and emission probabilities 
The transition and emission probabilities of the multivariate HMM were 
trained in a semi-supervised manner using GENCODE annotations in the following steps: 
1. The genomic bins obtained from section 3.2 were overlapped with 
GENCODE transcripts to identify “gencode bins”. 
2. For individual transcript IDs, the gencode bins were classified as TSS, 
exon, intron, and TTS bins based on their overlap with gencode 
transcript components. The rank of each exon and intron bins was 
obtained from GENCODE. 
3. For each gencode transcript, the coverage (in bp) of individual TU 
elements (e.g. TSS, 1st exon, 1st intron, 2nd exon, 2nd intron, etc) was 
computed i.e for each 200 bp bin 𝐵, the number of bps overlapping 
with individual TU components was computed. Finally, a coverage 
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table 𝑇𝑚×𝑛 was created, where, m = number of bins overlapping the 
transcript and n = number of hidden states (in this case n=number of TU 
states). Each value of the coverage matrix represents the coverage (in 
bps) of the 200bp bin for the TU hidden state. The coverage tables for 
individual transcript IDs were combined to a coverage list, where each 
entry in the list contains the coverage table for a transcript ID. 
4. The transition probabilities between TU states were computed from 
the coverage list generated in Step 3. The missing transition 
probabilities from and to the background states and also between the 
background states were generated in an unsupervised manner. 
5. The coverage list and class matrix were filtered to identify transcripts 
and bins that were enriched for Pol II. This was done by performing a 
k-means clustering for all the TSS and TTS bins of the class matrix and 
identifying the bin cluster that reported a high cluster mean for Pol II. 
The emission probabilities for each TU state was computed from the 
filtered class matrix and coverage list. The emission probabilities of 
background states were trained in an unsupervised manner. 
3.5 Binarization of Nascent RNA-seq profiles 
The nascent RNA TUs for K562 were obtained from Schwalb et al (Schwalb et 
al., 2016), while, the TUs for HepG2 and IMR90 were obtained from GRO-seq profiles 
using groHMM (Chae, Danko and Kraus, 2015). The TUs for HepG2 were obtained using 
groHMM with default parameters, whereas, for IMR90, the TUs were obtained with 
parameter values specified in  Chae et al (Chae, Danko and Kraus, 2015). Hence, for a cell 
line 𝐶, the binary enrichment i.e. presence or absence of nascent RNA-seq signal across 
the 200 bp bins 𝐸𝐶(𝑏𝑖𝑛, 𝑛𝑎𝑠𝑐𝑒𝑛𝑡 𝑅𝑁𝐴) is given by: 
𝐸𝐶(𝑏𝑖𝑛, 𝑁𝑎𝑠𝑐𝑒𝑛𝑡𝑅𝑁𝐴) = {
1
0
𝑖𝑓𝑂(𝑏𝑖𝑛, 𝑇𝑈𝑛𝑎𝑠𝑐𝑒𝑛𝑡) ≥ 1
𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒
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where 𝑂(𝑏𝑖𝑛, 𝑇𝑈𝑛𝑎𝑠𝑐𝑒𝑛𝑡) represents the degree of overlap between the 200 bp bin and the 
nascent RNA TUs in cell line 𝐶. 
3.6 Binarization of RNA-seq profiles 
The aligned reads from RNA-seq experiments were assembled using genome-
guided assemblers StringTie and Cufflinks to identify genome-wide TUs. For both 
StringTie and Cufflinks, the genome-wide TUs were obtained from aligned reads using 
GRCh37 gencode gene annotation (Harrow et al., 2012) with the parameter setting –G and 
--rf (for StringTie) and –g and --rf (for Cufflinks). The binary enrichment of RNA-seq 
signal in cell line 𝐶 across the 200 bp bins 𝐸𝐶(𝑏𝑖𝑛, 𝑅𝑁𝐴) is given by: 
𝐸𝐶(𝑏𝑖𝑛, 𝑅𝑁𝐴) = {
1
0




where 𝑂(𝑏𝑖𝑛, 𝑇𝑈𝑅𝑁𝐴) represents the degree of overlap between the 200 bp bin and the 
RNA-seq TUs in cell line 𝐶 that was obtained from StringTie and Cufflinks. 
3.7 Validation with gene annotations and RNA-seq 
To efficiently validate the fraction of EPIGENE predictions explained by 
existing annotations and RNA-seq approaches, a consensus TU set was created by 
combining the gene annotations (obtained from GENCODE and CHESS) with the 
predictions of EPIGENE, StringTie and, Cufflinks in K562 cell line. This was done using 
the union method of the GenomicRanges package (Lawrence et al., 2013). After obtaining 
the consensus TU set, a validation matrix was created. The validation matrix 𝑉 is a 𝑚 × 𝑛, 
where, 𝑚 corresponds to the total number of genomic regions of the consensus TU set, 
and 𝑛 corresponds to the types of datasets combined to form the consensus TU set. In this 
case, 𝑛 = 3, as we combined three different kinds of datasets namely, EPIGENE 
predictions, gene annotations (GENCODE+CHESS) and, predictions from RNA-seq based 
approaches (StringTie + Cufflinks). Each entry of the validation matrix represents if the 
genomic region of the consensus TU set overlaps with the corresponding predictions or 
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annotations. The validation matrix was then used to calculate the summary statistics 
shown in Figure 7, and the results were plotted using Upset (Lex et al., 2014). 
3.8 Performance evaluation 
In section 2.3, I compared the performance of EPIGENE with existing RNA-
seq and chromatin segmentation approaches. The performance of all of these methods 
was evaluated at 200 bp resolution using Pol II and nascent RNA-seq signal as a 
performance indicator. The actual transcription status of each bin 𝑇𝐴𝑐𝑡𝑢𝑎𝑙(𝑏𝑖𝑛) was given 
by: 
 𝑇𝐴𝑐𝑡𝑢𝑎𝑙(𝑏𝑖𝑛) = {
1
0




where, 𝐸𝐶(𝑏𝑖𝑛, 𝑃𝑜𝑙 𝐼𝐼) represents the presence or absence of Pol II ChIP-seq signal that was 
obtained in section 3.2.2 and 𝐸𝐶(𝑏𝑖𝑛, 𝑛𝑎𝑠𝑐𝑒𝑛𝑡 𝑅𝑁𝐴) represents the binary enrichment of 
the nascent RNA-seq signal in the bin that was obtained in section 3.5. 
The predicted transcription status of the bin for method 𝑚, 𝑇𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑(𝑏𝑖𝑛) was given by: 
𝑇𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑(𝑏𝑖𝑛)  = {
1
0
𝑖𝑓 𝑂(𝑏𝑖𝑛, 𝑇𝑈𝑚) ≥ 1
𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒
 
where, 𝑂(𝑏𝑖𝑛, 𝑇𝑈𝑚) represents the degree of overlap between the 200 bp 𝑏𝑖𝑛 and the TUs 
predicted by method 𝑚. 
The predictions of EPIGENE, RNA-seq, and chromatin segmentation 
approaches were evaluated by computing the AUC for ROC and PRC curve. Due to a very 
high class imbalance i.e. 𝑏𝑖𝑛𝑃𝑜𝑙 𝐼𝐼+ ≪  𝑏𝑖𝑛𝑃𝑜𝑙 𝐼𝐼−  , the AUC-ROC and AUC-PRC were 
computed by random sampling as: 




where, 𝑛𝑖 is the number of iterations and 𝐿𝐴𝑈𝐶  is the list of AUCs obtained for 𝑛𝑖 iterations. 
3.9 Identifying cell-specific TUs with negligible RNA-seq evidence 
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For identifying cell-specific EPIGENE TUs, a consensus TU set was created by 
combining the predictions of K562, HepG2, and IMR90 using the union method from the 
GenomicRanges package. This consensus set was divided into individual subsets based 
on the presence of a TU for a given cell line (Figure S5). The Pol II enrichment for each 
subset of TUs was obtained using the same strategy described in section 3.2. The RNA-
seq evidence for a TU is given by a binary value representing the overlap of the TU with 
StringTie or Cufflinks predictions. Lastly, each of the subsets was filtered for RNA-seq 
evidence to obtain valid cell-specific TU with negligible RNA-seq evidence. 
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4 Discussion and conclusion 
Parts of this chapter were published as a peer-reviewed research article in Epigenetics and 
Chromatin (Sahu et al. 2020). For detailed author contributions, please refer to Page xi. 
 
In this chapter, I critically discuss the existing TU prediction approaches and 
their limitations and the need for a chromatin-based TU prediction method. Additionally, 
I discuss the benefits and shortcomings of our novel chromatin-based TU prediction 
method and also suggest possible solutions to resolve the shortcomings.  
4.1 Genome-wide TU identification  
Accurate identification of genome-wide TU is essential for understanding the 
transcriptomic landscape of a cell and analyzing its differences across multiple cell types 
and conditions. Currently, due to efforts of several epigenomic consortia like ENCODE, 
Roadmap epigenomics, Blueprint, DEEP, CEEHRC, and IHEC the ChIP-seq profiles of 
transcription-associated histone modifications are now available across many cells types 
and tissues. This vast amount of data requires novel and efficient methods to analyze and 
integrate these data.  Hence, efficient methods to accomplish this task are crucial for 
current and future transcriptomic research and can potentially identify genome-wide 
active TUs.  
4.1.1  Modifying the strategy for genome-wide TU identification 
Recent advances in transcriptome sequencing have made it possible to 
identify and quantify genome-wide TUs in a cost-effective manner. As a result, most 
computational approaches for identifying genome-wide TUs are based on RNA-seq data. 
Although these approaches correctly identify stable mRNAs, they, however, fail to 
identify TUs that are transcribed to unstable regulatory RNAs such as microRNAs 
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precursors. Several recent studies have demonstrated the presence of many unstable TUs 
that are rapidly degraded (Preker et al., 2008; Tani et al., 2012; Li et al., 2013), some of which 
have been reported to be associated with diseases (Sethi and Lukiw, 2009; Bail et al., 2010; 
Shah et al., 2016; Wang, Qin and Tang, 2019; Zhang et al., 2019). 
Recently, nascent RNA-seq has also been developed for studying Pol II-
mediated transcription. However, majority of these approaches are limited to cell cultures 
and cannot be implemented in vivo. These shortcomings can be alleviated with a 
chromatin-based TU prediction method due to the availability of a vast amount of ChIP-
seq profiles of transcription-associated histone modifications. In the past, chromatin 
segmentation methods have been developed that identify genomic features like 
promoters, enhancers, transcribed regions, etc., using histone modifications. These 
methods, however, do not identify TUs as their model parameters do not capture the 
topology of a TU. 
4.1.2  Predicting TUs with histone modifications 
In this thesis, I developed a multivariate HMM called EPIGENE, which 
predicts genome-wide TUs using histone modifications. EPIGENE consists of two types 
of hidden states: TU states and background states. The TU states were trained in a 
supervised manner whereas the background states were trained in an unsupervised 
manner. This semi-supervised training captures the probability of occurrence of histone 
modifications in different components of an active TU (such as TSS, exon, intron, TTS, 
etc.) as well as the topology of the combination of histone modifications in active TUs. 
Additionally, duplicating the TU state sequence to run from TSS to TTS and vice versa 
also enables EPIGENE to capture the directionality of active TUs. 
4.2 Unbiased and accurate TU prediction by EPIGENE 
I validated the EPIGENE predictions with existing gene annotations, ChIP-
seq, and nascent RNA-seq profiles and show that majority of EPIGENE predictions can 
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be explained by GENCODE, CHESS, Pol II, and nascent RNA evidence. Additionally, a 
quantitative comparison with Pol II ChIP-seq and RNA-seq profiles revealed the presence 
of active TUs with negligible RNA-seq evidence. 
 I compared the performance of EPIGENE with existing RNA-seq (StringTie 
and Cufflinks) and chromatin segmentation (chromHMM) methods by defining a cell-
specific gold standard with Pol II and nascent RNA-seq as true transcription indicator. 
Based on AUC-PRC and AUC-ROC as performance metrics, EPIGENE reports a superior 
performance compared to RNA-seq and chromatin segmentation approaches. Additional 
performance evaluation across multiple cell lines showed that EPIGENE consistently 
achieves superior performance than RNA-seq and chromatin segmentation approaches 
and, therefore, can be reliably applied across different cell types and tissues without the 
need to retrain the model parameters. 
I examined other performance metrics like specificity, sensitivity, and 
precision and found that the low AUC of RNA-seq methods was due to RNA-seq 
mapping artifacts that result in higher false positives. Additionally, the extremely low 
AUC of Cufflinks is due to the usage of RABT assembler that further increases the number 
of false positives (Janes et al., 2015). Further evaluation of EPIGENE TUs across K562, 
IMR90, and HepG2 revealed the presence of cell-specific TUs with negligible RNA-seq 
evidence. Additionally, EPIGENE also predicts microRNA precursors that lack RNA-seq 
signal supposedly due to their unstable nature. 
4.3 Limitations of EPIGENE 
One of the major current shortcomings of EPIGENE is its inability to 
differentiate between the functional and non-functional elements (exons and introns) of a 
TU, as the association between alternative splicing and histone modifications is yet to be 
elucidated.  
Additionally, it is important to note that EPIGENE requires all the core histone 
modifications to efficiently predict genome-wide active TUs and the accuracy of TUs 
EPIgenomic GENE prediction  Discussion and conclusion 
Anshupa Sahu 72 
 
decreases in the absence of a core histone modification. However, all the histone 
modifications used as features in EPIGENE are available for many cell types and tissues 
and are consistently being generated for several cell types by many consortia like 
ENCODE and Roadmap Epigenome. In the absence of a core histone modification, 
imputation techniques such as PREDICTED and ChromImpute (Ernst and Kellis, 2015; 
Durham et al., 2018) can be used to impute the missing histone modification and then use 
the imputed histone modification along with the available histone modifications to 
identify genome-wide active TUs. 
EPIGENE also does not accurately identify complex TUs such as TUs with 
multiple active promoters. For such cases, EPIGENE predicts a new TU each time it 
encounters an active promoter and hence predicting multiple small TUs rather than 
predicting a single large TU. This problem can be resolved with a multimodal HMM by 
incorporating nascent RNA-seq data as features, in addition to the existing chromatin 
state features. Nascent RNA-seq data from TT-seq or mNET-seq can be used for this 
purpose, as both these techniques are known to reliably detect transcription termination 
(Wissink et al., 2019). 
4.4 Conclusion 
With recent advances in ChIP-seq and increasing efforts in the direction of 
epigenomics, several consortia continue to provide high-quality ChIP-seq profiles of 
transcription-associated histone modifications. However, determining the transcriptomic 
landscape and identifying genome-wide TUs with this data remains unexplored. During 
my Ph.D. research, I address this shortcoming by developing a novel chromatin-based TU 
prediction method, EPIGENE for predicting genome-wide active TUs. EPIGENE uses a 
semi-supervised strategy to train the HMM parameters which enables the efficient 
prediction of genome-wide TUs in both forward and reverse strands. Extensive 
validations and evaluation of EPIGENE predictions demonstrate its superior performance 
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over existing RNA-seq and chromatin segmentation approaches and its broader 
applicability across cell types and tissues. 
EPIGENE is user-friendly and can be executed by providing the aligned ChIP-
seq and control reads without the need to re-train the model. Its predictions strongly agree 
with Pol II and nascent RNA-seq data indicating their superior accuracy. Taken together, 
the superior performance, broader applicability, and ability to predict highly unstable TUs 
makes EPIGENE a valuable method to provide genome-wide TU annotations. EPIGENE 
annotations will improve current TU annotations as more data becomes available and 
additionally provide valuable insights about transcriptomic landscape across cell types 
and tissues. 
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6.1 List of datasets used 
 
Table S1: List of datasets used in this study 
Cell line Residue Sequencing Accession number Source 
IMR90 H3K27ac ChIP-seq ENCSR002YRE ENCODE 
IMR90 H3K4me3 ChIP-seq ENCSR087PFU ENCODE 
IMR90 H3K4me1 ChIP-seq ENCSR831JSP ENCODE 
IMR90 H3K36me3 ChIP-seq ENCSR437ORF ENCODE 
IMR90 H3K27me3 ChIP-seq ENCSR431UUY ENCODE 
IMR90 H3K9me3 ChIP-seq ENCSR055ZZY ENCODE 
IMR90 input ChIP-seq ENCSR001BSB, 
ENCSR704GTT 
ENCODE 
IMR90 Pol II-Input ChIP-seq ENCSR000EFL ENCODE 
IMR90 Pol II ChIP-seq ENCSR000EFK ENCODE 
IMR90 Poly A selected RNA RNA-seq ENCSR000CTQ ENCODE 
HepG2 Pol II-Input ChIP-seq ENCSR000EEM ENCODE 
HepG2 Pol II ChIP-seq ENCSR000EEN ENCODE 
HepG2 H3K27ac, H3K4me3, 
H3K4me1, H3K36me3, 
H3K27me3, H3K9me3, 
input, poly A selected 
RNA 
ChIP-seq EGAD00001002527 DEEP 





K562 Nascent RNA TT-Seq GSE75792 GEO 
K562 Nascent RNA GRO-Seq GSM1480325 GEO 
HepG2 Nascent RNA GRO-Seq GSM2428726 GEO 
IMR90 Nascent RNA GRO-Seq GSM1055806 GEO 
 
6.2 Summary statistics of EPIGENE, StringTie, and Cufflinks TUs 
 
Table S2: Summary statistics of EPIGENE predicted TUs in K562 
 genes + strand - strand median length 
all 24,571 13,410 11,161 7,800 
gencode V19 + chess 2.1 same 
strand overlap 
18,184 9,774 8, 410 9,800  
gencode V19 + chess 2.1 any overlap 23,542 12,921 10,621 8,400 
no match 1,029 489 540 2,000     
 
Table S3: Summary statistics of StringTie predicted TUs in K562 
 genes + strand - strand median length 
all 101,656 50,636 51,020 5,481 
gencode V19 + chess 2.1 same 
strand overlap 
93,006 46,448 46,558 6,719  
gencode V19 + chess 2.1 any overlap 97,300 48,531 48,769 6,110 
no match 4,356 2,105 2,251 613     
 
Table S4: Summary statistics of Cufflinks predicted TUs in K562 
 genes + strand - strand median length 
all 32,079 15,262 15,095 8,851 
 
 
gencode V19 + chess 2.1 same 
strand overlap 
26,452 12,986 12,671 16,486  
gencode V19 + chess 2.1 any overlap 27,157 13,320 13,042 15,392 
no match 4,992 1,942 2,053 962      
 
























Figure S3: Comparing K562-trained EPIGENE model, STRINGTIE and 














Figure S6: EPIGENE predicted TUs overlapping miRbase annotations across K562 
and IMR90 cell line 
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